| 2021-09-06 |
温馨提示：
美股因劳工节，9月6日休市一天
|
| 2018-01-11 |
复牌提示：
2018-01-11 08:11:19 停牌，复牌日期 2018-01-12 00:00:01
|
| 2017-11-02 |
股东大会：
将于2017-12-11召开股东大会
会议内容 ▼▲
- 1.Approval of the acquisition of Enzymotec by Frutarom Ltd., an Israeli company (“Frutarom”), including the approval of: (i) the Agreement and Plan of Merger, dated as of October 28, 2017, by and among Enzymotec, Frutarom, and Frutarom Tech Ltd., an Israeli company and a wholly-owned subsidiary of Frutarom (“Merger Sub”) (as it may be amended from time to time, the “merger agreement”); (ii) the merger of Merger Sub with and into Enzymotec (the “merger”) on the terms and subject to the conditions set forth in the merger agreement and in accordance with Sections 314-327 of the Israeli Companies Law, 1999, following which Merger Sub will cease to exist as a separate legal entity and Enzymotec will become a wholly-owned subsidiary of Frutarom; (iii) the consideration to be received by the shareholders of Enzymotec (other than Enzymotec, Frutarom or their respective wholly-owned subsidiaries) in the merger, consisting of $11.90 per share in cash, without interest and less any applicable withholding taxes, for each ordinary share of Enzymotec owned immediately prior to the effective time of the merger; and (iv) all other transactions and arrangements contemplated by the merger agreement, including, without limitation, the purchase by Enzymotec of a run-off directors’ and officers’ liability insurance policy for a period of seven years following the effective time of the merger.
2.a.Reelection of Holger Liepmann as a class I director of the Company, to serve until the Company’s Annual General Meeting of Shareholders in 2020 and until his successor is duly elected and qualified, or until his earlier resignation, replacement or removal.
2.b.Election of Amos Anatot as a class I director of the Company, to serve until the Company’s Annual General Meeting of Shareholders in 2020 and until his successor is duly elected and qualified, or until his earlier resignation, replacement or removal.
2.c.Election of Alon Shmuel Granot as a class I director of the Company, to serve until the Company’s Annual General Meeting of Shareholders in 2020 and until his successor is duly elected and qualified, or until his earlier resignation, replacement or removal.
2.d.Election of Ari Rosenthal as a class I director of the Company, to serve until the Company’s Annual General Meeting of Shareholders in 2020 and until his successor is duly elected and qualified, or until his earlier resignation, replacement or removal.
3.Approval of the reappointment of Kesselman & Kesselman, a member of PricewaterhouseCoopers International Limited, as the Company’s independent, external auditors for the year ending December 31, 2017 and until the next Annual General Meeting of Shareholders, and to authorize the Company’s board of directors (the “Board”) (with power of delegation to its audit committee) to set the fees to be paid to such auditors.
|
| 2017-10-30 |
详情>>
股本变动：
变动后总股本2342.81万股
|
| 2017-08-16 |
财报披露：
美东时间 2017-08-16 盘前发布财报
|
| 2017-03-16 |
详情>>
业绩披露：
2016年年报每股收益-0.13美元,归母净利润-292.3万美元,同比去年增长-143.74%
|
| 2017-03-10 |
股东大会：
将于2017-04-25召开股东大会
会议内容 ▼▲
- 1.To approve the compensation of Mr. Erez Israeli, the Company’s newly appointed President and Chief Executive Officer and, in connection therewith, approve a one-time increase in the number of ordinary shares available for grant under the Company’s 2013 Omnibus Equity Incentive Plan.
2.The Board of Directors unanimously recommends that shareholders vote FOR the above proposal, which will be described in a proxy statement to be made available to the Company’s shareholders.
3.The shareholders may also act upon such other matters as may properly come before the Meeting or any adjournment or postponement thereof.
|
| 2016-07-14 |
股东大会：
将于2016-08-25召开股东大会
会议内容 ▼▲
- 1. To reelect Mr. Steve Dubin as a class III director of the Company, to serve until the Company’s Annual General Meeting of Shareholders in 2019 and until his successor is duly elected and qualified;
2. To reelect Ms. Michal Silverberg as a class III director of the Company, to serve until the Company’s Annual General Meeting of Shareholders in 2019 and until her successor is duly elected and qualified;
3. To reelect Mr. Joseph Tenne as a class III director of the Company, to serve until the Company’s Annual General Meeting of Shareholders in 2019 and until his successor is duly elected and qualified;
4. To reelect Mr. Dov Pekelman as a class I director of the Company, to serve until the Company’s Annual General Meeting of Shareholders in 2017 and until his successor is duly elected and qualified;
5. To approve the payment of modified cash remuneration to the Israeli members of the Company’s Board of Directors (currently comprised of Messrs. Joseph Tenne, Nir Belzer, Dov Pekelman, Yossi Peled, Mani Wasserman, and Ms. Michal Silverberg), consisting of annual cash fees, meeting/consent participation fees and reimbursement of expenses;
6. To approve the payment of modified meeting/consent participation fees to the non-Israeli members of the Company’s Board of Directors;
7. To approve a one-time grant of equity-based compensation to all members of the Company’s Board of Directors, consisting of options to purchase ordinary shares and restricted stock units (“RSUs”);
8. To approve payment of a bonus to the Company’s President and Chief Executive Officer, Dr. Ariel Katz, in respect of his performance during the year ended December 31, 2015
9. To approve the reappointment of Kesselman & Kesselman, a member of PricewaterhouseCoopers International Limited, as the Company’s independent, external auditors for the year ending December 31, 2016 and until the next Annual General Meeting of Shareholders, and to authorize the Company’s Board of Directors (with power of delegation to its audit committee) to set the fees to be paid to such auditors.
|
| 2016-03-03 |
详情>>
业绩披露：
2015年年报每股收益0.30美元,归母净利润668.30万美元,同比去年增长-14.74%
|
| 2015-06-25 |
股东大会：
将于2015-07-29召开股东大会
会议内容 ▼▲
- 1.To reelect each of (a) Dr. Immanuel (Mani) Wasserman and (b) Mr. Nir Belzer as a Class II director of the Company, to serve as a director for a three-year term, until the company's annual general meeting of shareholders in 2018, and until his successor is duly elected and qualified;
2.To elect Ms. Tamar Howson as a Class II director of the Company, to serve as a director for a three-year term, until the company's annual general meeting of shareholders in 2018, and until her successor is duly elected and qualified, and to approve her compensation terms;
3.To approve the reappointment of Kesselman & Kesselman, a member of PricewaterhouseCoopers International Limited, as the Company's independent, external auditors for the year ending December 31, 2015 and until the next annual general meeting of shareholders, and to authorize the Company’s Board of Directors, or the Board, with power of delegation to its audit committee, to set the fees to be paid to such auditors.
|
| 2015-03-02 |
详情>>
业绩披露：
2014年年报每股收益0.36美元,归母净利润783.80万美元,同比去年增长-31.22%
|
| 2015-01-22 |
股东大会：
将于2015-02-12召开股东大会
会议内容 ▼▲
- 1.To elect Mr. Holger Liepmann as a class I director of our Company to serve until our annual general meeting in 2017 and to approve his compensation terms;
2.To approve changes in compensation terms for four members of our board of directors;
3.To approve equity grants to Dr. Ariel Katz, our President and Chief Executive Officer.
|
| 2014-09-03 |
股东大会：
将于2014-09-29召开股东大会
会议内容 ▼▲
- 1. To reelect Mr. Yossi Peled to serve as a director of the Company for a three year term; B. To reelect Mr. Jacob (Yaacov) Bachar to serve as a director of the Company for a three year term;
2. To approve the reappointment of Kesselman & Kesselman, a member of PricewaterhouseCoopers International Limited, as the Company's independent, external auditors for the year ending December 31, 2014 and until the next annual general meeting of shareholders, and to authorize the Company’s Board of Directors to set the fees to be paid to such auditors;
3. To act upon such other matters as may properly come before the meeting or any adjournment or postponement thereof.
|
| 2014-05-30 |
股东大会：
将于2014-06-26召开股东大会
会议内容 ▼▲
- 1. To approve a compensation policy for directors and other office holders of the Company in accordance with the requirements of the Israeli Companies Law, 5759-1999, pursuant to which shareholder approval for the compensation policy must be obtained within nine (9) months of the Company's initial public offering;
2. the majority voted in favor of the proposal must include a majority of the shares held by non-controlling shareholders who do not have a personal interest in the approval of the proposal that are voted at the meeting, excluding abstentions;
3. the total number of shares held by non-controlling, disinterested shareholders (as described in the previous bullet-point) voted against the proposal must not exceed two percent (2%) of the aggregate voting rights in the Company.
|
| 2014-02-13 |
详情>>
业绩披露：
2013年年报每股收益0.66美元,归母净利润1139.50万美元,同比去年增长138.29%
|
| 2013-11-08 |
股东大会：
将于2013-12-19召开股东大会
会议内容 ▼▲
- (1). to ratify the election of Ms. Michal Silverberg and Mr. Joseph Tenne as external directors of the Company, subject to, and in accordance with, the provisions of the Israeli Companies Law-1999 (the “Companies Law”);
(2). to approve, upon recommendation of the Board of Directors of the Company (the “Board”) and in compliance with the requirements of the Companies Law, the grant of a bonus, following the successful completion of the Company’s initial public offering, in the form of restricted shares to Mr. Yoav Doppelt, Chairman of the Board;
(3). to approve, upon recommendation of the Board and in compliance with the requirements of the Companies Law, the amendment of the terms of compensation provided to Prof. Dov Pekelman for services provided to Enzymotec as a member of the Board.
|
| 2013-09-16 |
详情>>
业绩披露：
2012年年报每股收益0.33美元,归母净利润478.20万美元,同比去年增长653.47%
|
| 2013-09-16 |
详情>>
业绩披露：
2013年中报每股收益0.30美元,归母净利润469.00万美元,同比去年增长455.03%
|